Disseminated Thrombosis in COVID-19 Cases: The Role of Early Antithrombotic Treatments?

Many newly published articles have focused on the association between COVID-19 and thrombogenicity. Indeed, it has become a frequently observed phenomena. In this study, we report on a 45-year-old man with a COVID-19-positive test. His dramatic progression started 5 days after admission. He develope...

Full description

Bibliographic Details
Main Authors: Jasem Mohammed Alhashmi, Ashraf M. Elhoufi, Eman Elhatou, Mahmood Ghanaim
Format: Article
Language:English
Published: Karger Publishers 2020-12-01
Series:Dubai Medical Journal
Subjects:
Online Access:https://www.karger.com/Article/FullText/509906
Description
Summary:Many newly published articles have focused on the association between COVID-19 and thrombogenicity. Indeed, it has become a frequently observed phenomena. In this study, we report on a 45-year-old man with a COVID-19-positive test. His dramatic progression started 5 days after admission. He developed a right ventricular (RV) thrombus (rare condition) and multiple brain sites infarction. We discuss this phenomena by showing the extent to which the thrombosis can take place, the possible relation between inflammatory, D-dimer and case progression and suggest a treatment approach particularly in cases with multiple thrombogenicity organ involvement.
ISSN:2571-726X